In today’s podcast Investorideas interviews Deepak Anand, the Co-Founder and CEO of Materia Ventures, where we discussed the cannabis and CBD industry in the E.U., Canadian and US compliance and the global cannabis industry moving forward.
Materia Ventures is a company seeking to be the leader in cannabis extraction for European markets. Their goal is to provide pure, tested and high-efficacy extract medicines for patients. Materia has built a team of experts with extensive experience in the pharmaceutical industry in order to provide products that patients can trust.
Mr Anand has been recognized as a thought leader in the global cannabis space and is a government relations and regulatory expert. Mr. Anand was the Executive Director of the Canadian National Medical Marijuana Association (CNMMA). Mr. Anand was also an Adjunct Professor at Kwantlen Polytechnic University (KPU) and helped develop curriculum for Canada's University level course in the Cannabis industry specific to ACMPR regulations.
Anand was also previously Vice President of Zenabis and is a board member for various pharmaceutical associations across Canada, the United States and Europe.
Mr Anand discussed how Materia Ventures has found unique opportunities in Europe and how his background in compliance and regulations has aided the company in navigating the challenges of the EU cannabis market. He also went on to discuss the current issues facing the US and Canadian cannabis and CBD markets when it comes to regulations and infrastructure.
Materia Ventures is a company seeking to be the leader in cannabis extraction for European markets. Their goal is to provide pure, tested and high-efficacy extract medicines for patients. Materia has built a team of experts with extensive experience in the pharmaceutical industry in order to provide products that patients can trust.
Mr Anand has been recognized as a thought leader in the global cannabis space and is a government relations and regulatory expert. Mr. Anand was the Executive Director of the Canadian National Medical Marijuana Association (CNMMA). Mr. Anand was also an Adjunct Professor at Kwantlen Polytechnic University (KPU) and helped develop curriculum for Canada's University level course in the Cannabis industry specific to ACMPR regulations.
Anand was also previously Vice President of Zenabis and is a board member for various pharmaceutical associations across Canada, the United States and Europe.
Mr Anand discussed how Materia Ventures has found unique opportunities in Europe and how his background in compliance and regulations has aided the company in navigating the challenges of the EU cannabis market. He also went on to discuss the current issues facing the US and Canadian cannabis and CBD markets when it comes to regulations and infrastructure.
for keeping him as a VP.